NYSE:WATLife Sciences
Waters Targets Biopharma And Battery Growth With New Analytical Platforms
Waters Corporation (NYSE:WAT) has launched new BioResolve and GTxResolve Columns aimed at speeding impurity analysis in biopharmaceutical workflows.
The company introduced two mass spectrometry platforms, the Cyclic IMS P20 and Xevo MRT P10, designed to increase speed, sensitivity, and multiomics capabilities.
Waters also released a new Coin Cell DSC instrument focused on safer battery development and testing.
Waters, known for its analytical instruments and consumables, is leaning into...